Medicines

Fulltext search

For help on how to get the results you want, see our search tips.

Search results

653 results

Medicine European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter Referrals Remove Referrals filter Direct healthcare professional communication Remove Direct healthcare professional communication filter

Medicine type Accelerated assessment Remove Accelerated assessment filter Additional monitoring Remove Additional monitoring filter Generic Remove Generic filter

Categories Human Remove Human filter

Sort by

List item

Human medicine European public assessment report (EPAR): Lojuxta (updated)

Lomitapide, Hypercholesterolemia
Date of authorisation: 31/07/2013, , , Revision: 13, Authorised, Last updated: 27/01/2021
List item

Human medicine European public assessment report (EPAR): Actelsar HCT (updated)

telmisartan, hydrochlorothiazide, Essential Hypertension
Date of authorisation: 13/03/2013, , Revision: 12, Authorised, Last updated: 27/01/2021
List item

Human medicine European public assessment report (EPAR): Lutathera (updated)

lutetium (177Lu) oxodotreotide, Neuroendocrine Tumors
Date of authorisation: 26/09/2017, , , Revision: 4, Authorised, Last updated: 27/01/2021
List item

Human medicine European public assessment report (EPAR): Tenofovir disoproxil Mylan (updated)

tenofovir disoproxil, HIV Infections
Date of authorisation: 08/12/2016, , Revision: 11, Authorised, Last updated: 27/01/2021
List item

Human medicine European public assessment report (EPAR): Darzalex (updated)

Daratumumab, Multiple Myeloma
Date of authorisation: 20/05/2016, , , , Revision: 15, Authorised, Last updated: 26/01/2021
List item

Human medicine European public assessment report (EPAR): Tecentriq (updated)

atezolizumab, Carcinoma, Transitional Cell, Carcinoma, Non-Small-Cell Lung, Urologic Neoplasms, Breast Neoplasms, Small Cell Lung Carcinoma
Date of authorisation: 20/09/2017, , Revision: 12, Authorised, Last updated: 26/01/2021
List item

Human medicine European public assessment report (EPAR): COVID-19 Vaccine Moderna (updated)

CX-024414 (single-stranded, 5’-capped messenger RNA (mRNA) produced using a cell-free in vitro transcription from the corresponding DNA templates, encoding the viral spike (S) protein of SARS-CoV-2), COVID-19 virus infection
Date of authorisation: 06/01/2021, , , Authorised, Last updated: 26/01/2021
List item

Human medicine European public assessment report (EPAR): Takhzyro (updated)

lanadelumab, Angioedemas, Hereditary
Date of authorisation: 22/11/2018, , , , Revision: 4, Authorised, Last updated: 25/01/2021
List item

Human medicine European public assessment report (EPAR): Ocaliva (updated)

Obeticholic acid, Liver Cirrhosis, Biliary
Date of authorisation: 12/12/2016, , , , Revision: 8, Authorised, Last updated: 25/01/2021
List item

Human medicine European public assessment report (EPAR): Clopidogrel ratiopharm GmbH (updated)

clopidogrel, Peripheral Vascular Diseases, Acute Coronary Syndrome, Myocardial Infarction, Stroke
Date of authorisation: 28/07/2009, , Revision: 12, Withdrawn, Last updated: 25/01/2021
List item

Human medicine European public assessment report (EPAR): Ofev (updated)

nintedanib, Idiopathic Pulmonary Fibrosis
Date of authorisation: 14/01/2015, , Revision: 17, Authorised, Last updated: 25/01/2021
List item

Human medicine European public assessment report (EPAR): Ocrevus (updated)

ocrelizumab, Multiple Sclerosis
Date of authorisation: 08/01/2018, , Revision: 9, Authorised, Last updated: 22/01/2021
List item

Human medicine European public assessment report (EPAR): Symkevi (updated)

tezacaftor, ivacaftor, Cystic Fibrosis
Date of authorisation: 31/10/2018, , , Revision: 7, Authorised, Last updated: 22/01/2021
List item

Human medicine European public assessment report (EPAR): Dupixent (updated)

dupilumab, Dermatitis, Atopic
Date of authorisation: 27/09/2017, , Revision: 9, Authorised, Last updated: 22/01/2021
List item

Human medicine European public assessment report (EPAR): Blincyto (updated)

blinatumomab, Precursor Cell Lymphoblastic Leukemia-Lymphoma
Date of authorisation: 23/11/2015, , , Revision: 11, Authorised, Last updated: 22/01/2021
List item

Human medicine European public assessment report (EPAR): Kalydeco (updated)

ivacaftor, Cystic Fibrosis
Date of authorisation: 23/07/2012, , , Revision: 27, Authorised, Last updated: 22/01/2021
List item

Human medicine European public assessment report (EPAR): Tremfya (updated)

guselkumab, Psoriasis
Date of authorisation: 10/11/2017, , Revision: 5, Authorised, Last updated: 22/01/2021
List item

Human medicine European public assessment report (EPAR): Ervebo (updated)

recombinant vesicular stomatitis virus (strain indiana) with a deletion of the envelope glycoprotein, replaced with the zaire ebolavirus (strain kikwit 1995) surface glycoprotein, Hemorrhagic Fever, Ebola
Date of authorisation: 11/11/2019, , Revision: 2, Authorised, Last updated: 22/01/2021
List item

Human medicine European public assessment report (EPAR): Wakix (updated)

pitolisant, Narcolepsy
Date of authorisation: 31/03/2016, , , Revision: 9, Authorised, Last updated: 21/01/2021
List item

Human medicine European public assessment report (EPAR): Mysimba (updated)

bupropion hydrochloride, naltrexone hydrochloride, Obesity, Overweight
Date of authorisation: 26/03/2015, , Revision: 18, Authorised, Last updated: 21/01/2021
List item

Human medicine European public assessment report (EPAR): Oncaspar (updated)

pegaspargase, Precursor Cell Lymphoblastic Leukemia-Lymphoma
Date of authorisation: 14/01/2016, , Revision: 12, Authorised, Last updated: 21/01/2021
List item

Human medicine European public assessment report (EPAR): Recarbrio (updated)

imipenem monohydrate, cilastatin sodium, relebactam monohydrate, Gram-Negative Bacterial Infections
Date of authorisation: 13/02/2020, , Revision: 1, Authorised, Last updated: 19/01/2021
List item

Human medicine European public assessment report (EPAR): Roteas (updated)

edoxaban tosylate, Stroke, Venous Thromboembolism
Date of authorisation: 19/04/2017, , Revision: 8, Authorised, Last updated: 19/01/2021
List item

Human medicine European public assessment report (EPAR): Incruse Ellipta (previously Incruse) (updated)

umeclidinium bromide, Pulmonary Disease, Chronic Obstructive
Date of authorisation: 28/04/2014, , Revision: 14, Authorised, Last updated: 18/01/2021
List item

Human medicine European public assessment report (EPAR): Clopidogrel TAD (updated)

clopidogrel (as hydrochloride), Peripheral Vascular Diseases, Stroke, Myocardial Infarction
Date of authorisation: 23/09/2009, , Revision: 12, Authorised, Last updated: 18/01/2021